Saturday / July 19. 2025
menu-logo menu-logo
brand-logo
Subscribe
Subscribe
Saturday / July 19. 2025
  • Read
    • Daily News
      • Financial
      • Insights
      • U.S.
      • International
    • Digital Issue
    • Executive Announcements
    • Cover Stories
    • Feature Articles
      • Exclusive Interviews
    • International Focus
    • Company Spotlights
    • Forward Thinking
    • Legal Briefs
    • Insights from the Outside
    • For You | For Your Field
    • Working Smart
  • Listen & Watch
    • Direct Approach Podcast
    • SHIFT podcast
    • The DSN Podcast
  • Attend
    • AI Deep Dive 2025
    • DSU Fall 2025
  • Achieve
    • Global 100 List
    • Bravo Awards
    • Best Places to Work
    • Legends
  • Research
    • Stock Watch
    • The DSN Guide
    • Supplier Directory
    • Stock Ticker
    • Resources
  • Engage
    • Supporter Program
    • VIP Text Alerts
  • About
    • About DSN
    • Subscribe
    • Advertise
    • Connect
  • Search
Subscribe

Medifast Announces Q3 2024 Results

BY DSN Staff Writer | November 05, 2024 | read / Daily News / Financial

Medifast, parent company of OPTAVIA, reported its third quarter 2024 financial results. Revenue for the quarter was $140.2 million, a 40.6% year-over-year decline. This decrease was primarily driven by lower OPTAVIA coach productivity and fewer active earning OPTAVIA coaches, which decreased by 36.3% from the same period last year.

Gross profit during the quarter declined 40.4% to $105.7 million from $177.4 million in the same quarter last year. Income from operations was $2.1 million, a 91.7% decrease from the prior year period, and was 1.5% as a percentage of revenue. Net income during the quarter was $1.1 million, or $0.10 per diluted share, down significantly from $23.1 million and $2.12 per diluted share in the third quarter of 2023.

The company reported a balance sheet of $170 million in cash, cash equivalents and investment securities with no debt, up from $150 million at the end of 2023. Guidance for fourth quarter 2024 includes revenue between $100 million and $120 million with a diluted loss per share in the range of $0.10 to $0.65.

“Medical innovation has transformed the weight loss industry, so at Medifast we’re creating a health and wellness business of the future by meeting the unique needs of customers regardless of their approach to their health goals,” said Dan Chard, Medifast Chairman & CEO. “We offer comprehensive support for medication users including access to clinicians through LifeMD, as well as programs and products to help maintain muscle and minimize side effects. We’re developing customized solutions for those looking to maintain their weight and build a healthier lifestyle beyond medication usage. Importantly, our clinically-studied coach-led program remains a powerful solution for those not using medications at all, combining the community support, a habit-based approach and nutritional products that are a hallmark of all our OPTAVIA programs, having already helped over 3 million people achieve improved health. With tailored plans, personal solutions and a focused approach to driving customer acquisition, we believe that our strategy can drive sustainable growth in the quarters and years ahead.”

Posted in Daily News, Financial and tagged Dan Chard, Medifast, OPTAVIA, quarterly.
Related Articles
Olive Tree People Sees 70% Growth in First Half of 2025 July 17, 2025

Olive Tree People Sees 70% Growth in First Half of 2025

Read more
Bravenly Celebrates $9 Million Month July 11, 2025

Bravenly Celebrates $9 Million Month

Read more
Zinzino Reports Record-Breaking Q2 Revenue July 07, 2025

Zinzino Reports Record-Breaking Q2 Revenue

Read more
brand-logo
The News You Need.
The Name You Trust.
Subscribe

Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

  • Read
  • Listen & Watch
  • Attend
  • Achieve
  • Research
  • About
  • Connect
5717 Legacy Drive
Suite 250
Plano, Texas 75024
info@directsellingnews.com
Copyright 2025 Direct Selling News | All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Subscribe
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT